Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 293 entries
Sorted by: Best Match Show Resources per page
Differences in risk factors for hepatitis B, hepatitis C, and human immunodeficiency virus infection by ethnicity: A large population-based cohort study in British …

community settings

Binka M, Butt ZA, McKee G.
GSID: yRcFROCgs-gJ
M Binka, ZA Butt, G McKee, M Darvishian… - International Journal of …, 2021 - Elsevier

Objectives Addressing the needs of ethnic minorities will be key to finding undiagnosed individuals living with hepatitis B (HBV), hepatitis C (HCV), or human immunodeficiency …

Cite
Binka, M., Butt, Z. A., McKee, G., Darvishian, M., Cook, D., Wong, S., ... & Janjua, N. Z. (2021). Differences in risk factors for hepatitis B, hepatitis C, and human immunodeficiency virus infection by ethnicity: A large population-based cohort study in British Columbia, Canada. International Journal of Infectious Diseases, 106, 246-253.
Binka, Mawuena, et al. "Differences in risk factors for hepatitis B, hepatitis C, and human immunodeficiency virus infection by ethnicity: A large population-based cohort study in British Columbia, Canada." International Journal of Infectious Diseases 106 (2021): 246-253.
Copy Download .nbib Format: MLA
Proposition 4: the graduate of a masters program who plans to teach in an integrated baccalaureate nursing program should be prepared in more than one clinical nursing specialty.

NLN publications

Longway I, Lind DC, Powers EF, Link M, Mathwig G.
PMID: 5200684
NLN Publ. 1970;(15):26-30.

No abstract available.

Cite
Longway I, Lind DC, Powers EF, et al. Proposition 4: the graduate of a masters program who plans to teach in an integrated baccalaureate nursing program should be prepared in more than one clinical nursing specialty. NLN Publ. 1970;(15):26-30
Longway, I., Lind, D. C., Powers, E. F., Link, M., & Mathwig, G. (1970). Proposition 4: the graduate of a masters program who plans to teach in an integrated baccalaureate nursing program should be prepared in more than one clinical nursing specialty. NLN publications, (15), 26-30.
Longway, I, et al. "Proposition 4: the graduate of a masters program who plans to teach in an integrated baccalaureate nursing program should be prepared in more than one clinical nursing specialty." NLN publications vol. ,15 (1970): 26-30.
Longway I, Lind DC, Powers EF, Link M, Mathwig G. Proposition 4: the graduate of a masters program who plans to teach in an integrated baccalaureate nursing program should be prepared in more than one clinical nursing specialty. NLN Publ. 1970;(15):26-30. PMID: 5200684.
Copy Download .nbib Format: NLM
Electropolymerized three-dimensional randomly branched EDOT-containing copolymers.

Langmuir : the ACS journal of surfaces and colloids

Link SM, Scheuble M, Goll M, Muks E, Ruff A, Hoffmann A, Richter TV, Lopez Navarrete JT, Ruiz Delgado MC, Ludwigs S.
PMID: 24266499
Langmuir. 2013 Dec 10;29(49):15463-73. doi: 10.1021/la403050c. Epub 2013 Nov 22.

The potential of 2,2';3,2″-terthiophene (3T) as branching units in 3D copolymers is presented with EDOT as an example comonomer. Branched EDOT/3T polythiophenes were prepared by electropolymerization, and their electrochemical and optical properties are discussed. Two different approaches were employed:...

Cite
Link SM, Scheuble M, Goll M, et al. Electropolymerized three-dimensional randomly branched EDOT-containing copolymers. Langmuir. 2013;29(49):15463-73doi: 10.1021/la403050c.
Link, S. M., Scheuble, M., Goll, M., Muks, E., Ruff, A., Hoffmann, A., Richter, T. V., Lopez Navarrete, J. T., Ruiz Delgado, M. C., & Ludwigs, S. (2013). Electropolymerized three-dimensional randomly branched EDOT-containing copolymers. Langmuir : the ACS journal of surfaces and colloids, 29(49), 15463-73. https://doi.org/10.1021/la403050c
Link, Steffen M, et al. "Electropolymerized three-dimensional randomly branched EDOT-containing copolymers." Langmuir : the ACS journal of surfaces and colloids vol. 29,49 (2013): 15463-73. doi: https://doi.org/10.1021/la403050c
Link SM, Scheuble M, Goll M, Muks E, Ruff A, Hoffmann A, Richter TV, Lopez Navarrete JT, Ruiz Delgado MC, Ludwigs S. Electropolymerized three-dimensional randomly branched EDOT-containing copolymers. Langmuir. 2013 Dec 10;29(49):15463-73. doi: 10.1021/la403050c. Epub 2013 Nov 22. PMID: 24266499.
Copy Download .nbib Format: NLM
Prevalence, clinical consequences and management of acute faecal incontinence with diarrhoea in the ICU: The FIRST™ Observational Study.

Journal of the Intensive Care Society

Binks R, De Luca E, Dierkes C, Franci A, Herrero E, Niederalt G.
PMID: 28979434
J Intensive Care Soc. 2015 Nov;16(4):294-301. doi: 10.1177/1751143715589327. Epub 2015 Jun 30.

There are limited data on the incidence and management of acute faecal incontinence with diarrhoea in the ICU. The FIRST™ Observational Study was undertaken to obtain data on clinical practices used in the ICU for the management of acute...

Cite
Binks R, De Luca E, Dierkes C, et al. Prevalence, clinical consequences and management of acute faecal incontinence with diarrhoea in the ICU: The FIRST™ Observational Study. J Intensive Care Soc. 2015;16(4):294-301doi: 10.1177/1751143715589327.
Binks, R., De Luca, E., Dierkes, C., Franci, A., Herrero, E., & Niederalt, G. (2015). Prevalence, clinical consequences and management of acute faecal incontinence with diarrhoea in the ICU: The FIRST™ Observational Study. Journal of the Intensive Care Society, 16(4), 294-301. https://doi.org/10.1177/1751143715589327
Binks, Rachel, et al. "Prevalence, clinical consequences and management of acute faecal incontinence with diarrhoea in the ICU: The FIRST™ Observational Study." Journal of the Intensive Care Society vol. 16,4 (2015): 294-301. doi: https://doi.org/10.1177/1751143715589327
Binks R, De Luca E, Dierkes C, Franci A, Herrero E, Niederalt G. Prevalence, clinical consequences and management of acute faecal incontinence with diarrhoea in the ICU: The FIRST™ Observational Study. J Intensive Care Soc. 2015 Nov;16(4):294-301. doi: 10.1177/1751143715589327. Epub 2015 Jun 30. PMID: 28979434; PMCID: PMC5606465.
Copy Download .nbib Format: NLM
Open Access-Is There a Predator at the Door?.

JAMA otolaryngology-- head & neck surgery

Piccirillo JF, Chandra R, Fisher EW, Jones TM, Kennedy DW, Kraus DH, Krouse JH, Link M, Lustig LR, O'Malley BW, Ruben R, Sataloff RT, Sindwani R, Smith RJ, Stewart MG, Weber PC, Welling DB, Youngs R, Bs MB.
PMID: 29450479
JAMA Otolaryngol Head Neck Surg. 2018 Apr 01;144(4):289-290. doi: 10.1001/jamaoto.2018.0026.

No abstract available.

Cite
Piccirillo JF, Chandra R, Fisher EW, et al. Open Access-Is There a Predator at the Door?. JAMA Otolaryngol Head Neck Surg. 2018;144(4):289-290doi: 10.1001/jamaoto.2018.0026.
Piccirillo, J. F., Chandra, R., Fisher, E. W., Jones, T. M., Kennedy, D. W., Kraus, D. H., Krouse, J. H., Link, M., Lustig, L. R., O'Malley, B. W., Ruben, R., Sataloff, R. T., Sindwani, R., Smith, R. J., Stewart, M. G., Weber, P. C., Welling, D. B., Youngs, R., & Bs, M. B. (2018). Open Access-Is There a Predator at the Door?. JAMA otolaryngology-- head & neck surgery, 144(4), 289-290. https://doi.org/10.1001/jamaoto.2018.0026
Piccirillo, Jay F, et al. "Open Access-Is There a Predator at the Door?." JAMA otolaryngology-- head & neck surgery vol. 144,4 (2018): 289-290. doi: https://doi.org/10.1001/jamaoto.2018.0026
Piccirillo JF, Chandra R, Fisher EW, Jones TM, Kennedy DW, Kraus DH, Krouse JH, Link M, Lustig LR, O'Malley BW, Ruben R, Sataloff RT, Sindwani R, Smith RJ, Stewart MG, Weber PC, Welling DB, Youngs R, Bs MB. Open Access-Is There a Predator at the Door?. JAMA Otolaryngol Head Neck Surg. 2018 Apr 01;144(4):289-290. doi: 10.1001/jamaoto.2018.0026. PMID: 29450479.
Copy Download .nbib Format: NLM
Arsenic concentration in the urine of patients with Blackfoot disease and Bowen's disease.

Biological trace element research

Lin SM, Chiang CH, Yang MH.
PMID: 24259224
Biol Trace Elem Res. 1985 Aug;8(1):11-8. doi: 10.1007/BF02917599.

Extensive epidemiological study implicates that high arsenic content in artesian well water is the causal factor responsible for Blackfoot disease. We determine the arsenic concentration in urine samples of patients with Blackfoot and Bowen's diseases and examine whether there...

Cite
Lin SM, Chiang CH, Yang MH. Arsenic concentration in the urine of patients with Blackfoot disease and Bowen's disease. Biol Trace Elem Res. 1985;8(1):11-8doi: 10.1007/BF02917599.
Lin, S. M., Chiang, C. H., & Yang, M. H. (1985). Arsenic concentration in the urine of patients with Blackfoot disease and Bowen's disease. Biological trace element research, 8(1), 11-8. https://doi.org/10.1007/BF02917599
Lin, S M, et al. "Arsenic concentration in the urine of patients with Blackfoot disease and Bowen's disease." Biological trace element research vol. 8,1 (1985): 11-8. doi: https://doi.org/10.1007/BF02917599
Lin SM, Chiang CH, Yang MH. Arsenic concentration in the urine of patients with Blackfoot disease and Bowen's disease. Biol Trace Elem Res. 1985 Aug;8(1):11-8. doi: 10.1007/BF02917599. PMID: 24259224.
Copy Download .nbib Format: NLM
Particles at interfaces: general discussion.

Faraday discussions

Striolo A, Kim J, Murphy C, Liz-Marzán L, Lahann J, Reguera J, Zhou Y, Brust M, Thill A, Scarabelli L, König TA, Buzza M, Kuttner C, Gonzalez Solveyra E, Wolf H, Vermant J, Pauly M, Harvie A, Pasquato L, Stocco A, Mattoussi H, Kumacheva E, Heatley K, Hanske C, Faller R, French D, Honciuc A, Binks B, Sicard F.
PMID: 27711905
Faraday Discuss. 2016 Oct 06;191:407-434. doi: 10.1039/C6FD90050J.

No abstract available.

Cite
Striolo A, Kim J, Murphy C, et al. Particles at interfaces: general discussion. Faraday Discuss. 2016;191:407-434doi: 10.1039/C6FD90050J.
Striolo, A., Kim, J., Murphy, C., Liz-Marzán, L., Lahann, J., Reguera, J., Zhou, Y., Brust, M., Thill, A., Scarabelli, L., König, T. A., Buzza, M., Kuttner, C., Gonzalez Solveyra, E., Wolf, H., Vermant, J., Pauly, M., Harvie, A., Pasquato, L., Stocco, A., Mattoussi, H., Kumacheva, E., Heatley, K., Hanske, C., Faller, R., French, D., Honciuc, A., Binks, B., & Sicard, F. (2016). Particles at interfaces: general discussion. Faraday discussions, 191407-434. https://doi.org/10.1039/C6FD90050J
Striolo, Alberto, et al. "Particles at interfaces: general discussion." Faraday discussions vol. 191 (2016): 407-434. doi: https://doi.org/10.1039/C6FD90050J
Striolo A, Kim J, Murphy C, Liz-Marzán L, Lahann J, Reguera J, Zhou Y, Brust M, Thill A, Scarabelli L, König TA, Buzza M, Kuttner C, Gonzalez Solveyra E, Wolf H, Vermant J, Pauly M, Harvie A, Pasquato L, Stocco A, Mattoussi H, Kumacheva E, Heatley K, Hanske C, Faller R, French D, Honciuc A, Binks B, Sicard F. Particles at interfaces: general discussion. Faraday Discuss. 2016 Oct 06;191:407-434. doi: 10.1039/C6FD90050J. PMID: 27711905.
Copy Download .nbib Format: NLM
Revalidation--what is the problem and what are the possible solutions?.

The Medical journal of Australia

Links MJ.
PMID: 24835710
Med J Aust. 2014 May 19;200(9):521. doi: 10.5694/mja14.00400.

No abstract available.

Cite
Links MJ. Revalidation--what is the problem and what are the possible solutions?. Med J Aust. 2014;200(9):521doi: 10.5694/mja14.00400.
Links, M. J. (2014). Revalidation--what is the problem and what are the possible solutions?. The Medical journal of Australia, 200(9), 521. https://doi.org/10.5694/mja14.00400
Links, Matthew J. "Revalidation--what is the problem and what are the possible solutions?." The Medical journal of Australia vol. 200,9 (2014): 521. doi: https://doi.org/10.5694/mja14.00400
Links MJ. Revalidation--what is the problem and what are the possible solutions?. Med J Aust. 2014 May 19;200(9):521. doi: 10.5694/mja14.00400. PMID: 24835710.
Copy Download .nbib Format: NLM
Self-assembled LiFePO4 nanowires with high rate capability for Li-ion batteries.

Chemical communications (Cambridge, England)

Peng L, Zhao Y, Ding Y, Yu G, Banks M.
PMID: 25011485
Chem Commun (Camb). 2014 Aug 28;50(67):9569-72. doi: 10.1039/c4cc04036h.

Controlling the dimensions in the nanometer scale of olivine-type LiFePO4 has been regarded as one of the most effective strategies to improve its electrochemical performance for Li-ion batteries. In this communication, we demonstrate a novel LiFePO4 nanoarchitecture, which is...

Cite
Peng L, Zhao Y, Ding Y, et al. Self-assembled LiFePO4 nanowires with high rate capability for Li-ion batteries. Chem Commun (Camb). 2014;50(67):9569-72doi: 10.1039/c4cc04036h.
Peng, L., Zhao, Y., Ding, Y., Yu, G., & Banks, M. (2014). Self-assembled LiFePO4 nanowires with high rate capability for Li-ion batteries. Chemical communications (Cambridge, England), 50(67), 9569-72. https://doi.org/10.1039/c4cc04036h
Peng, Lele, et al. "Self-assembled LiFePO4 nanowires with high rate capability for Li-ion batteries." Chemical communications (Cambridge, England) vol. 50,67 (2014): 9569-72. doi: https://doi.org/10.1039/c4cc04036h
Peng L, Zhao Y, Ding Y, Yu G, Banks M. Self-assembled LiFePO4 nanowires with high rate capability for Li-ion batteries. Chem Commun (Camb). 2014 Aug 28;50(67):9569-72. doi: 10.1039/c4cc04036h. PMID: 25011485.
Copy Download .nbib Format: NLM
Phase I-II study of gamma interferon and 5-fluorouracil for patients with metastatic renal cell carcinoma.

Cancer biotherapy & radiopharmaceuticals

DeLima M, Amato RJ, Jackson A, Tu SM, Banks M, Finn L, Ellerhorst J.
PMID: 10851489
Cancer Biother Radiopharm. 1997 Dec;12(6):365-70. doi: 10.1089/cbr.1997.12.365.

We have completed a phase I/II trial to evaluate the toxicity and efficacy of the combination of gamma interferon and 5-fluorouracil in metastatic renal cell carcinoma. Gamma interferon was administered at a weekly dose of 100 micrograms. 5-fluorouracil was...

Cite
DeLima M, Amato RJ, Jackson A, et al. Phase I-II study of gamma interferon and 5-fluorouracil for patients with metastatic renal cell carcinoma. Cancer Biother Radiopharm. 1997;12(6):365-70doi: 10.1089/cbr.1997.12.365.
DeLima, M., Amato, R. J., Jackson, A., Tu, S. M., Banks, M., Finn, L., & Ellerhorst, J. (1997). Phase I-II study of gamma interferon and 5-fluorouracil for patients with metastatic renal cell carcinoma. Cancer biotherapy & radiopharmaceuticals, 12(6), 365-70. https://doi.org/10.1089/cbr.1997.12.365
DeLima, et al. "Phase I-II study of gamma interferon and 5-fluorouracil for patients with metastatic renal cell carcinoma." Cancer biotherapy & radiopharmaceuticals vol. 12,6 (1997): 365-70. doi: https://doi.org/10.1089/cbr.1997.12.365
DeLima M, Amato RJ, Jackson A, Tu SM, Banks M, Finn L, Ellerhorst J. Phase I-II study of gamma interferon and 5-fluorouracil for patients with metastatic renal cell carcinoma. Cancer Biother Radiopharm. 1997 Dec;12(6):365-70. doi: 10.1089/cbr.1997.12.365. PMID: 10851489.
Copy Download .nbib Format: NLM
Ladder operator for the one-dimensional Hubbard model.

Physical review letters

Links J, Zhou HQ, McKenzie RH, Gould MD.
PMID: 11384430
Phys Rev Lett. 2001 May 28;86(22):5096-9. doi: 10.1103/PhysRevLett.86.5096.

The one-dimensional Hubbard model is integrable in the sense that it has an infinite family of conserved currents. We explicitly construct a ladder operator which can be used to iteratively generate all of the conserved current operators. This construction...

Cite
Links J, Zhou HQ, McKenzie RH, et al. Ladder operator for the one-dimensional Hubbard model. Phys Rev Lett. 2001;86(22):5096-9doi: 10.1103/PhysRevLett.86.5096.
Links, J., Zhou, H. Q., McKenzie, R. H., & Gould, M. D. (2001). Ladder operator for the one-dimensional Hubbard model. Physical review letters, 86(22), 5096-9. https://doi.org/10.1103/PhysRevLett.86.5096
Links, J, et al. "Ladder operator for the one-dimensional Hubbard model." Physical review letters vol. 86,22 (2001): 5096-9. doi: https://doi.org/10.1103/PhysRevLett.86.5096
Links J, Zhou HQ, McKenzie RH, Gould MD. Ladder operator for the one-dimensional Hubbard model. Phys Rev Lett. 2001 May 28;86(22):5096-9. doi: 10.1103/PhysRevLett.86.5096. PMID: 11384430.
Copy Download .nbib Format: NLM
Critical assessment of microarray data analysis: the 2001 challenge.

Bioinformatics (Oxford, England)

Johnson KF, Lin SM.
PMID: 11590109
Bioinformatics. 2001 Sep;17(9):857-8. doi: 10.1093/bioinformatics/17.9.857.

UNLABELLED: We initiated the Critical Assessment of Microarray Data Analysis (CAMDA) conference to stimulate and evaluate the development of advanced data analysis techniques for microarrays. A standard data set has been released for this data analysis challenge. The goal...

Cite
Johnson KF, Lin SM. Critical assessment of microarray data analysis: the 2001 challenge. Bioinformatics. 2001;17(9):857-8doi: 10.1093/bioinformatics/17.9.857.
Johnson, K. F., & Lin, S. M. (2001). Critical assessment of microarray data analysis: the 2001 challenge. Bioinformatics (Oxford, England), 17(9), 857-8. https://doi.org/10.1093/bioinformatics/17.9.857
Johnson, K F, and Lin, S M. "Critical assessment of microarray data analysis: the 2001 challenge." Bioinformatics (Oxford, England) vol. 17,9 (2001): 857-8. doi: https://doi.org/10.1093/bioinformatics/17.9.857
Johnson KF, Lin SM. Critical assessment of microarray data analysis: the 2001 challenge. Bioinformatics. 2001 Sep;17(9):857-8. doi: 10.1093/bioinformatics/17.9.857. PMID: 11590109.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 293 entries